Ductal carcinoma in situ in patients younger than 30 years: differences in adjuvant endocrine therapy and outcomes
Author:
Funder
National Cancer Institute
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-020-06014-5.pdf
Reference23 articles.
1. Narod SA, Iqbal J, Giannakeas V et al (2015) Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol 1:888–896. https://doi.org/10.1001/jamaoncol.2015.2510
2. Jones CE, Richman J, Jackson BE et al (2018) Treatment patterns for ductal carcinoma in situ with close or positive mastectomy margins. J Surg Res 231:36–42. https://doi.org/10.1016/j.jss.2018.05.007
3. Sagara Y, Freedman RA, Wong SM et al (2017) Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004–2013. Breast Cancer Res Treat 166:583–592. https://doi.org/10.1007/s10549-017-4436-9
4. Van Bockstal MR, Agahozo MC, Koppert LB, van Deurzen CHM (2020) A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast. Int J Cancer 146:1189–1197. https://doi.org/10.1002/ijc.32362
5. Nguyen TT, Hoskin TL, Day CN et al (2017) Factors influencing use of hormone therapy for ductal carcinoma in situ: a National Cancer Database Study. Ann Surg Oncol 24:2989–2998. https://doi.org/10.1245/s10434-017-5930-3
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Endocrine therapy initiation among women diagnosed with ductal carcinoma in situ from 2001 to 2018;Breast Cancer Research and Treatment;2024-08-16
2. Clinical presentations and outcomes of young women aged <40 yrs with Ductal carcinoma in situ;Breast Disease;2023-09-25
3. A juvenile female with ductal carcinoma In situ arising from a fibroadenoma;Journal of Cancer Research and Practice;2023
4. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI‐Based Radiomics;Journal of Magnetic Resonance Imaging;2022-11-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3